Protalix BioTherapeutics Shares Outstanding 2006-2019 | PLX

Protalix BioTherapeutics shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Protalix BioTherapeutics Annual Shares Outstanding
(Millions of Shares)
2018 147
2017 131
2016 101
2015 95
2014 93
2013 92
2012 91
2011 85
2010 81
2009 77
2008 76
2007 67
2006 29
2005 19
Protalix BioTherapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 148
Q2 2019 148
Q1 2019 148
Q4 2018 147
Q3 2018 148
Q2 2018 147
Q1 2018 145
Q4 2017 131
Q3 2017 133
Q2 2017 193
Q1 2017 124
Q4 2016 101
Q3 2016 100
Q2 2016 100
Q1 2016 100
Q4 2015 95
Q3 2015 94
Q2 2015 94
Q1 2015 93
Q4 2014 93
Q3 2014 93
Q2 2014 93
Q1 2014 93
Q4 2013 92
Q3 2013 92
Q2 2013 92
Q1 2013 92
Q4 2012 91
Q3 2012 92
Q2 2012 95
Q1 2012 88
Q4 2011 85
Q3 2011 86
Q2 2011 86
Q1 2011 82
Q4 2010 81
Q3 2010 81
Q2 2010 81
Q1 2010 81
Q4 2009 77
Q3 2009 77
Q2 2009 76
Q1 2009 76
Q4 2008 76
Q3 2008 76
Q2 2008 76
Q1 2008 76
Q4 2007 67
Q3 2007 66
Q2 2007 66
Q1 2007 64
Q4 2006 29
Q3 2006 26
Q2 2006 19
Q1 2006 19
Q4 2005 19
Q3 2005 0
Q2 2005 0
Q1 2005 0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.031B $0.034B
Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx(R). Protalix's unique expression system presents a proprietary method for developing recombinant proteins in a cost-effective, industrial-scale manner. Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved for marketing by the U.S. Food and Drug Administration (FDA) in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.499B 15.15
CSL (CSLLY) Australia $82.574B 0.00
Gilead Sciences (GILD) United States $81.374B 10.08
Celgene (CELG) United States $78.289B 11.18
Biogen (BIIB) United States $52.581B 9.02
Vertex Pharmaceuticals (VRTX) United States $52.423B 53.51
Illumina (ILMN) United States $43.472B 47.70
Regeneron Pharmaceuticals (REGN) United States $38.266B 16.75
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.218B 11.96
Seattle Genetics (SGEN) United States $18.962B 0.00
Incyte (INCY) United States $18.554B 43.07
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.254B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.630B 0.00
Genmab (GNMSF) Denmark $13.346B 74.86
Galapagos (GLPG) Belgium $10.444B 26.91
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Exact Sciences (EXAS) United States $10.375B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.129B 0.00
BeiGene (BGNE) Cayman Islands $9.321B 0.00
Bio-Techne Corp (TECH) United States $7.773B 52.03
Amarin (AMRN) Ireland $7.480B 0.00
Sarepta Therapeutics (SRPT) United States $7.451B 0.00
QIAGEN (QGEN) Netherlands $7.275B 23.72
ACADIA Pharmaceuticals (ACAD) United States $7.136B 0.00
Guardant Health (GH) United States $6.908B 0.00
Moderna (MRNA) United States $5.995B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.662B 14.40
Reata Pharmaceuticals (RETA) United States $5.504B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.856B 0.00
Ascendis Pharma (ASND) Denmark $4.687B 0.00
Exelixis (EXEL) United States $4.661B 13.11
China Biologic Products (CBPO) China $4.538B 28.33
Repligen (RGEN) United States $4.306B 78.04
Spark Therapeutics (ONCE) United States $4.298B 0.00
Medicines (MDCO) United States $4.256B 0.00
Bluebird Bio (BLUE) United States $4.219B 0.00
Mirati Therapeutics (MRTX) United States $4.114B 0.00
Adaptive Biotechnologies (ADPT) United States $3.524B 0.00
Blueprint Medicines (BPMC) United States $3.499B 0.00
Immunomedics (IMMU) United States $3.364B 0.00
MorphoSys AG (MOR) Germany $3.306B 0.00
Alkermes (ALKS) Ireland $3.134B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.958B 0.00
Emergent Biosolutions (EBS) United States $2.856B 28.37
Genmab (GMAB) Denmark $2.834B 5.84
Intercept Pharmaceuticals (ICPT) United States $2.718B 0.00
MyoKardia (MYOK) United States $2.519B 0.00
Halozyme Therapeutics (HALO) United States $2.454B 0.00
NeoGenomics (NEO) United States $2.410B 128.92
Acceleron Pharma (XLRN) United States $2.381B 0.00
UniQure (QURE) Netherlands $2.354B 0.00
Amicus Therapeutics (FOLD) United States $2.350B 0.00
Arena Pharmaceuticals (ARNA) United States $2.313B 5.38
Zai Lab (ZLAB) China $2.242B 0.00
RA PHARMCTL INC (RARX) United States $2.206B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.142B 0.00
Cambrex (CBM) United States $2.018B 25.47
Ligand Pharmaceuticals (LGND) United States $1.905B 36.65
Akcea Therapeutics (AKCA) United States $1.806B 0.00
Myriad Genetics (MYGN) United States $1.800B 26.59
Insmed (INSM) United States $1.697B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.627B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.453B 0.00
Denali Therapeutics (DNLI) United States $1.442B 0.00
REGENXBIO (RGNX) United States $1.405B 0.00
Zymeworks (ZYME) Canada $1.392B 0.00
Epizyme (EPZM) United States $1.369B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.332B 0.00
Coherus BioSciences (CHRS) United States $1.292B 0.00
Innoviva (INVA) United States $1.245B 3.67
Zealand Pharma (ZLDPF) Denmark $1.143B 0.00
Alector (ALEC) United States $1.123B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.123B 0.00
Sangamo Therapeutics (SGMO) United States $1.115B 0.00
Editas Medicine (EDIT) United States $1.105B 0.00
Fate Therapeutics (FATE) United States $1.097B 0.00
Zealand Pharma (ZEAL) Denmark $1.000B 11.23
WAVE Life Sciences (WVE) Singapore $0.969B 0.00
Athenex (ATNX) United States $0.905B 0.00
Arvinas (ARVN) United States $0.896B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.888B 0.00
Codexis (CDXS) United States $0.888B 0.00
Cara Therapeutics (CARA) United States $0.868B 0.00
Anika Therapeutics (ANIK) United States $0.863B 27.99
Vericel (VCEL) United States $0.858B 320.08
Pharming Group (PHGUF) Netherlands $0.799B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.796B 6.70
ZIOPHARM Oncology Inc (ZIOP) United States $0.760B 0.00
Principia Biopharma (PRNB) United States $0.749B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.734B 0.00
Twist Bioscience (TWST) United States $0.729B 0.00
Heska (HSKA) United States $0.722B 184.42
ANI Pharmaceuticals (ANIP) United States $0.701B 11.95
Revance Therapeutics (RVNC) United States $0.684B 0.00
DBV Technologies S.A (DBVT) France $0.683B 0.00
Intellia Therapeutics (NTLA) United States $0.656B 0.00
MiMedx (MDXG) United States $0.653B 0.00
Mesoblast (MESO) Australia $0.610B 0.00
GENFIT S.A (GNFT) France $0.606B 0.00
UROGEN PHARMA (URGN) United States $0.575B 0.00
Adverum Biotechnologies (ADVM) United States $0.564B 0.00
Cellectis S.A (CLLS) France $0.564B 0.00
Retrophin (RTRX) United States $0.557B 0.00
BioDelivery Sciences (BDSI) United States $0.524B 0.00
Agenus (AGEN) United States $0.511B 0.00
Intra-Cellular Therapies (ITCI) United States $0.507B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Kadmon Holdings (KDMN) United States $0.479B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
Cytokineticsorporated (CYTK) United States $0.470B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Precision BioSciences (DTIL) United States $0.455B 0.00
PHARMA MAR SA (PHMMF) Spain $0.445B 0.00
Stemline Therapeutics (STML) United States $0.422B 0.00
AC Immune SA (ACIU) Switzerland $0.378B 28.00
Merus (MRUS) Netherlands $0.377B 0.00
Prothena (PRTA) Ireland $0.376B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.373B 2.58
Arcus Biosciences (RCUS) United States $0.369B 0.00
Dynavax Technologies (DVAX) United States $0.366B 0.00
Cellular Biomedicine (CBMG) United States $0.348B 0.00
PDL BioPharma (PDLI) United States $0.335B 8.37
Bellus Health (BLU) Canada $0.330B 0.00
Puma Biotechnology (PBYI) United States $0.329B 0.00
Kindred Biosciences (KIN) United States $0.323B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.312B 0.00
Pfenex (PFNX) United States $0.309B 0.00
Avid Bioservices (CDMO) United States $0.305B 0.00
Clovis Oncology (CLVS) United States $0.300B 0.00
Theratechnologies (THTX) Canada $0.299B 0.00
AnaptysBio (ANAB) United States $0.290B 0.00
Geron (GERN) United States $0.288B 0.00
Compugen (CGEN) Israel $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.276B 0.00
Gritstone Oncology (GRTS) United States $0.263B 0.00
Scholar Rock Holding (SRRK) United States $0.259B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
Biofrontera AG (BFRA) Germany $0.253B 378.53
MannKind (MNKD) United States $0.252B 0.00
CytomX Therapeutics (CTMX) United States $0.250B 0.00
Sutro Biopharma (STRO) United States $0.249B 0.00
ADMA Biologics Inc (ADMA) United States $0.249B 0.00
Inovio Pharmaceuticals (INO) United States $0.242B 0.00
Cel-Sci (CVM) United States $0.239B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.233B 0.00
Albireo Pharma (ALBO) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.231B 0.00
Kamada (KMDA) Israel $0.221B 8.45
Sorrento Therapeutics (SRNE) United States $0.215B 0.00
Syros Pharmaceuticals (SYRS) United States $0.213B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Cue Biopharma (CUE) United States $0.210B 0.00
Athersys (ATHX) United States $0.208B 0.00
XOMA (XOMA) United States $0.207B 0.00
Spero Therapeutics (SPRO) United States $0.200B 0.00
Exicure (XCUR) United States $0.196B 0.00
OSMOTICA PHARM (OSMT) United States $0.196B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.190B 0.00
Palatin Technologies (PTN) United States $0.185B 5.43
Senesco Technologies (ELOX) United States $0.175B 0.00
Arsanis (XFOR) United States $0.174B 0.00
ChromaDex (CDXC) United States $0.169B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.167B 0.00
Dyadic (DYAI) United States $0.158B 0.00
Affimed (AFMD) Germany $0.157B 0.00
Alcobra (ARCT) United States $0.156B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Cerecor (CERC) United States $0.148B 0.00
Prometic Life Sciences (PFSCF) Canada $0.146B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.146B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.144B 0.00
Five Prime Therapeutics (FPRX) United States $0.142B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
Emmaus Life Sciences (EMMA) United States $0.135B 0.00
CorMedix Inc (CRMD) United States $0.135B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Ophthotech (ISEE) United States $0.133B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.131B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.128B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Menlo Therapeutics (MNLO) United States $0.115B 0.00
Abeona Therapeutics (ABEO) United States $0.113B 0.00
Fortress Biotech (FBIO) United States $0.113B 0.00
Mersana Therapeutics (MRSN) United States $0.110B 0.00
Aptinyx (APTX) United States $0.110B 0.00
Novavax (NVAX) United States $0.110B 0.00
NantKwest (NK) United States $0.109B 0.00
BioTime (LCTX) United States $0.107B 5.52
PHASEBIO PHARMA (PHAS) United States $0.105B 0.00
OvaScience (MLND) United States $0.104B 0.00
VBI Vaccines (VBIV) United States $0.102B 0.00
Acorda Therapeutics (ACOR) United States $0.095B 0.00
Antibe Therapeutics (ATBPF) Canada $0.091B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.090B 0.00
Strongbridge Biopharma (SBBP) United States $0.090B 2.40
Adaptimmune Therapeutics (ADAP) United Kingdom $0.090B 0.00
Celyad SA (CYAD) Belgium $0.089B 0.00
Aduro Biotech (ADRO) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.077B 0.00
Verastem (VSTM) United States $0.077B 0.00
ARAVIVE, INC (ARAV) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Trevena (TRVN) United States $0.071B 0.00
Synlogic (SYBX) United States $0.070B 0.00
Checkpoint Therapeutics (CKPT) United States $0.069B 0.00
Selecta Biosciences (SELB) United States $0.067B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.064B 0.00
Liquidia Technologies (LQDA) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
Orgenesis (ORGS) United States $0.053B 3.42
Sunesis Pharmaceuticals (SNSS) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.052B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.051B 0.00
Organovo Holdings (ONVO) United States $0.051B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.046B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
Curis (CRIS) United States $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.043B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.037B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Unum Therapeutics (UMRX) United States $0.034B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.97
VIVUS (VVUS) United States $0.029B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Celsion (CLSN) United States $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Alimera Sciences (ALIM) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.016B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TrovaGene (TROV) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.002B 0.00